Search Within

Matthew David Hellmann

  1. "Weinberg Fellows"
Formats
  1. Journal Article (56)
  2. Meeting Abstract (43)
  3. Correspondence (1)
  4. Research Letter (1)
  5. Review (1)
Groups
  1. Department of Medicine (102)
  2. Solid Tumor Oncology Division (102)
  3. Thoracic Oncology (102)
  4. Weinberg Fellows (102)
  5. GSK Faculty (61)
  6. Department of Pathology and Laboratory Medicine (55)

More Groups

People
  1. Hira Rizvi (54)
  2. Charles Rudin (43)
  3. Kathryn Arbour (40)
  4. Gregory Riely (39)
  5. Mark Kris (38)
  6. Marc Ladanyi (34)

More People

Years
  1. 2024 (4)
  2. 2023 (6)
  3. 2022 (13)
  4. 2021 (14)
  5. 2020 (20)
  6. 2019 (19)

More Years

Publications
  1. Journal of Clinical Oncology (31)
  2. Journal of Thoracic Oncology (15)
  3. Annals of Oncology (13)
  4. Clinical Cancer Research (7)
  5. Cancer Cell (3)
  6. JCO Precision Oncology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (34)
  2. Elsevier Inc. (22)
  3. Oxford University Press (16)
  4. American Association for Cancer Research (13)
  5. Nature Publishing Group (6)
  6. Cell Press (3)

More Publishers

Results (102)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Intratumoral escherichia is associated with improved survival to single-agent immune checkpoint inhibition in patients with advanced non–small-cell lung cancer
    Journal Article

    Elkrief, A.; Montesion, M.; Sivakumar, S.; Hale, C.; Bowman, A. S.; Begüm Bektaş, A.; Bradic, M.; Kang, W.; Chan, E.; Gogia, P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Antibiotics are associated with worse outcomes in lung cancer patients treated with chemotherapy and immunotherapy
    Journal Article

    Elkrief, A.; Méndez-Salazar, E. O.; Maillou, J.; Vanderbilt, C. M.; Gogia, P.; Desilets, A.; Messaoudene, M.; Kelly, D.; Ladanyi, M.; Hellmann, M. D.; more...
    npj Precision Oncology (2024)

    Fulltext@MSK | Save
  • Immune-related colitis is associated with fecal microbial dysbiosis and can be mitigated by fecal microbiota transplantation
    Journal Article

    Elkrief, A.; Waters, N. R.; Smith, N.; Dai, A.; Slingerland, J.; Aleynick, N.; Febles, B.; Gogia, P.; Socci, N. D.; Lumish, M.; more...
    Cancer Immunology Research (2024)

    Fulltext@MSK | Save
  • Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer
    Journal Article

    Memon, D.; Schoenfeld, A. J.; Ye, D.; Fromm, G.; Rizvi, H.; Zhang, X.; Keddar, M. R.; Mathew, D.; Yoo, K. J.; Qiu, J.; more...
    Cancer Cell (2024)

    Fulltext@MSK | Save
  • Outcomes of combination platinum-doublet chemotherapy and anti-PD(L)-1 blockade in KRAS(G12C) mutant non-small cell lung cancer
    Journal Article

    Elkrief, A.; Riccuiti, B.; Alessi, J. V.; Fei, T.; Kalvin, H. L.; Egger, J. V.; Rizvi, H.; Thummalapalli, R.; Lamberti, G.; Plodkowski, A.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Clinical and molecular features of long-term response to immune checkpoint inhibitors in patients with advanced non–small cell lung cancer
    Journal Article

    Thummalapalli, R.; Ricciuti, B.; Bandlamudi, C.; Muldoon, D.; Rizvi, H.; Elkrief, A.; Luo, J.; Alessi, J. V.; Pecci, F.; Lamberti, G.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Factors associated with disease progression after discontinuation of immunotherapy for immune-related toxicity in non-small cell lung cancer
    Meeting Abstract

    Pecci, F.; Thummalapalli, R.; Alden, S.; Ricciuti, B.; Alessi, J. V.; Elkrief, A.; Rizvi, H.; Wang, X.; Egger, J. V.; Vaz, V. R.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Fecal microbiota transplantation for refractory immune-checkpoint-inhibitor colitis
    Meeting Abstract

    Elkrief, A.; Nicholas, W.; Smith, N.; Dai, A.; Slingerland, J. B.; Aleynick, N.; Lumish, M. A.; Giardina, P.; Chaft, J. E.; Chapman, P. B.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Clinical benefit from immunotherapy in patients with SCLC is associated with tumor capacity for antigen presentation
    Journal Article

    Rudin, C. M.; Balli, D.; Lai, W. V.; Richards, A. L.; Nguyen, E.; Egger, J. V.; Choudhury, N. J.; Sen, T.; Chow, A.; Poirier, J. T.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: A cohort study
    Journal Article

    Elkrief, A.; Alessi, J. M. V.; Ricciuti, B.; Brown, S.; Rizvi, H.; Preeshagul, I. R.; Wang, X.; Pecci, F.; Di Federico, A.; Lamberti, G.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save